berberine has been researched along with Cardiotoxicity in 9 studies
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is a well-known natural compound with potential cardioprotective and autophagic modulatory properties." | 5.72 | Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination. ( Chen, B; Zhang, JP, 2022) |
| "The aim of this study was to evaluate the efficacy of solid lipid nanoparticles of berberine against doxorubicin-induced cardiotoxicity." | 4.12 | Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered ( Bhatnagar, P; Dinda, AK; Gupta, P; Rawal, S; Yadav, HN, 2022) |
| "Berberine (BBR) is a natural compound that exhibits cardioprotective effects and regulates calcium homeostasis." | 1.91 | Berberine attenuates sunitinib-induced cardiac dysfunction by normalizing calcium regulation disorder via SGK1 activation. ( Li, C; Qiu, S; Sun, J; Wang, X; Wu, W; Xing, J; Xu, Y; Yan, W; Zhang, J; Zhang, Z, 2023) |
| "Berberine (BBR) is a well-known natural compound with potential cardioprotective and autophagic modulatory properties." | 1.72 | Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination. ( Chen, B; Zhang, JP, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 8 (88.89) | 2.80 |
| Authors | Studies |
|---|---|
| Tabrizi, FB | 1 |
| Yarmohammadi, F | 1 |
| Hayes, AW | 1 |
| Karimi, G | 1 |
| Chen, B | 1 |
| Zhang, JP | 1 |
| Rawal, S | 1 |
| Gupta, P | 1 |
| Bhatnagar, P | 1 |
| Yadav, HN | 1 |
| Dinda, AK | 1 |
| Song, C | 1 |
| Li, D | 1 |
| Zhang, J | 2 |
| Zhao, X | 1 |
| Wang, Y | 3 |
| Liao, J | 1 |
| Luo, Y | 1 |
| Li, M | 1 |
| Su, X | 1 |
| Yu, B | 1 |
| Teng, J | 1 |
| Wang, H | 1 |
| Lv, X | 1 |
| Li, C | 1 |
| Wu, W | 1 |
| Xing, J | 1 |
| Yan, W | 1 |
| Sun, J | 1 |
| Zhang, Z | 1 |
| Qiu, S | 1 |
| Xu, Y | 1 |
| Wang, X | 2 |
| Wu, YZ | 1 |
| Zhang, L | 1 |
| Wu, ZX | 1 |
| Shan, TT | 1 |
| Xiong, C | 1 |
| Guan, X | 1 |
| Zheng, X | 1 |
| Vong, CT | 1 |
| Zhao, J | 1 |
| Xiao, J | 1 |
| Zhong, Z | 1 |
| Yang, Z | 1 |
| Zhao, L | 1 |
| He, Z | 1 |
1 review available for berberine and Cardiotoxicity
| Article | Year |
|---|---|
The modulation of SIRT1 and SIRT3 by natural compounds as a therapeutic target in doxorubicin-induced cardiotoxicity: A review.
Topics: Animals; Berberine; Cardiotoxicity; Dioxoles; Doxorubicin; Heart Diseases; Humans; Lignans; Myocardi | 2022 |
8 other studies available for berberine and Cardiotoxicity
| Article | Year |
|---|---|
Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
Topics: Animals; Apoptosis; Beclin-1; Berberine; Cardiotoxicity; Doxorubicin; Mitophagy; Myocytes, Cardiac; | 2022 |
Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
Topics: Animals; Apoptosis; Berberine; Cardiotoxicity; Doxorubicin; Inflammation; Lipids; Liposomes; Myocyte | 2022 |
Berberine hydrochloride alleviates imatinib mesylate - induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis.
Topics: Animals; Berberine; Biomarkers; Cardiotoxicity; Ferroptosis; Imatinib Mesylate; Iron; Mice; NF-E2-Re | 2023 |
Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
Topics: Animals; Apoptosis; Berberine; Cardiotoxicity; Doxorubicin; Fibrosis; Heart Injuries; Myocytes, Card | 2023 |
Berberine attenuates sunitinib-induced cardiac dysfunction by normalizing calcium regulation disorder via SGK1 activation.
Topics: Animals; Berberine; Calcium; Cardiotoxicity; Heart Diseases; Humans; Mice; Myocytes, Cardiac; Phosph | 2023 |
Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
Topics: Animals; Berberine; Cardiotoxicity; Cell Line; Doxorubicin; Electrocardiography; Male; Rats; Rats, S | 2019 |
Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Caco-2 Cells; Cardiotoxicity; Co | 2020 |
Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity.
Topics: Animals; Antineoplastic Agents; Berberine; Cardiotoxicity; Cell Line, Tumor; Female; Heart; Humans; | 2021 |